GNCAQ — Genocea Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$12.49m
- $1.64m
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc
U.S. STOCKS ON THE MOVE-Boeing Co, Cowen Inc, Carter's Inc
U.S. STOCKS ON THE MOVE-Phillips 66, Amazon.com Inc, Abbvie Inc
U.S. STOCKS ON THE MOVE-Tesla Inc, LianBio, Intel Corp
Genocea Biosciences hits record low on strategic review, workforce reduction plan
Brief: Genocea Biosciences Inc - As Result Of Workforce Reduction, Expects To Incur Personnel-Related Restructuring Charges Of Approximately $4 Million
Brief: Genocea Initiates Restructuring And Announces Plan To Explore Strategic Alternatives
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:22 PM
Genocea Biosciences Inc expected to post a loss of 18 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Astec Industries, ChampionX, Schlumberger NV
Genocea Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Genocea Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors
Genocea Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Genocea Biosciences Inc Has Entered Into Research And Development Collaboration And Option Agreement With Janssen Biotech Inc
U.S. STOCKS ON THE MOVE-American Airlines, Borr Drilling, InnovAge